drug
elironrasib
Phase 2updated 6mo agoby $RVMD Revolution Medicines, Inc.
Phase 2community read0 votes
indications
indications
NSCLC
all catalysts(0)
nothing on the calendar yet
Trials studying elironrasib
News(1)
- Drugmakers rush to pair up with Summit’s ivonescimab ahead of key verdictWith companies including AstraZeneca, Pfizer and Revolution Medicines clamoring to get in on Summit Therapeutics’ Akeso-partnered PD-1xVEGF antibody, one analyst calls the asset “the next major bac…biospace · 15d ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that